KEYTRUDA 100 MG-4 ML

Description :

keytruda is also used to treat a certain type of non- small cell lung cancer, if your tumor has a specific genetic marker for which your doctor will test.Keytruda 100mg was approved by the US Food and Drug Administration on an accelerated basis. In clinical studies, tumors responded to this medicine.  It is also used to treat head and neck cancer that has spread to other parts of the body, or has come back after prior treatment.

How to uses :

patients who are suffering from recurrent or metastatic HNSCC with disease progression on or after platinum-containing chemotherapy.200 mg IV over 30 minutes every 3 weeks until disease progression, unacceptable toxicity, or up to 24 months in patients without disease progression.Adult and pediatric patients who are suffering from refractory cHL, or who have relapsed after 3 or more prior lines of therapy.Patients who are suffering from metastatic melanoma.

Work :

It works in blocking a protective mechanism on the cancer cells, and it allows the immune system to destroy those cancer cells. The drug was initially used to treat the metastatic melanoma.Before you start treatment, your doctor will perform tests to make sure Keytruda is the best treatment for your type of skin cancer.Keytruda 100 mg-4 ml can cause certain side effects by changing the way your immune system works.

How to take :

You may requirement to have a negative pregnancy test before starting this treatment. Do not use Keytruda if you are pregnant. Pembrolizumab could harm the unborn baby. Use effective birth control to prevent pregnancy while you are using this pills and for at least 4 months after your last dose. Some side effects may need to be treated with other drug, and your cancer treatments may be delayed or stopped altogether.You will need frequent medical tests to help your doctor determine if it is safe for you to keep receiving keytruda 100 mg. Your doctor or nurse will give you this pills. Kindly do not self administer.Do not miss any follow-up visits to your doctor.

Dosage :

HNSCC  the recommended dosage regimen is 200 mg every 3 weeks it is given as an intravenous infusion over 30min every 3 weeks until disease progression, without disease progression it up to 24 months in.Melanoma the starting recommended dosage regimen is 2 mg/kg it is given as an intravenous infusion over 30min every 3 weeks until disease progression, without disease progression it up to 24 months in patients.

Side effect :

ear congestion

feeling cold

fever

hair loss

headache

hoarseness or husky voice

loss of voice

fever

cough

feeling short of breath

pain in your muscles

bones

Warning :

Solid organ transplant  refusal reported in post-marketing setting. treatment may increase risk of  refusal in solid organ transplant recipients.consider benefit of treatment versus risk of possible organ  refusal.have immune system problem such as Crohn’s disease, ulcerative colitis, or lupus.have had an organ transplant.have lung or inspiration problem.have liver problems.

Storage :

Do not freeze the reconstituted or diluted solution. If the product is not used immediately, in-use storage times and conditions after opening before use are the responsibility of the user, the storage period may not exceed a total time of 24 hours. The retention period of 24 hours may include up to 6 hours at room temperature (at or below 25 ° C), moreover, the solution in the refrigerator at 2 ° C must be kept to 8 ° C.

            For More Visit Click Here : Genericday.com